Old Web
English
Sign In
Acemap
>
authorDetail
>
Hermann Fahrngruber
Hermann Fahrngruber
Novartis
Immunology
Pimecrolimus
Medicine
Lymphocyte
Tacrolimus
6
Papers
122
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Lymphocyte priming in murine contact hypersensitivity is affected less by pimecrolimus than by tacrolimus
2011
Josef G. Meingassner
Assadollah Bavandi
Hermann Fahrngruber
Frank Kalthoff
Show All
Source
Cite
Save
Citations (0)
Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
2008
American Journal of Pathology
Cornelia Halin
Hermann Fahrngruber
Josef G. Meingassner
Guido Bold
Amanda Littlewood-Evans
Anton Stuetz
Michael Detmar
Show All
Source
Cite
Save
Citations (71)
Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity
2006
Journal of Dermatological Science
Assadollah Bavandi
Hermann Fahrngruber
Heinrich Aschauer
B. Hartmann
Josef G. Meingassner
Frank Kalthoff
Show All
Source
Cite
Save
Citations (7)
Lymphocyte priming in murine contact hypersensitivity is affected less by pimecrolimus than by tacrolimus 1 1 Disclosure not available at press time.
2004
Journal of The American Academy of Dermatology
Josef G. Meingassner
Assadollah Bavandi
Hermann Fahrngruber
Frank Kalthoff
Show All
Source
Cite
Save
Citations (0)
Pimecrolimus Inhibits the Elicitation Phase but Does Not Suppress the Sensitization Phase in Murine Contact Hypersensitivity, in Contrast to Tacrolimus and Cyclosporine A1
2003
Journal of Investigative Dermatology
Josef G. Meingassner
Hermann Fahrngruber
Assadollah Bavandi
Show All
Source
Cite
Save
Citations (44)
1